ZA767416B - Prostaglandin analogs - Google Patents

Prostaglandin analogs

Info

Publication number
ZA767416B
ZA767416B ZA767416A ZA767416A ZA767416B ZA 767416 B ZA767416 B ZA 767416B ZA 767416 A ZA767416 A ZA 767416A ZA 767416 A ZA767416 A ZA 767416A ZA 767416 B ZA767416 B ZA 767416B
Authority
ZA
South Africa
Prior art keywords
prostaglandin analogs
prostaglandin
analogs
Prior art date
Application number
ZA767416A
Other languages
English (en)
Inventor
N Nelson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA767416B publication Critical patent/ZA767416B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA767416A 1975-12-29 1976-12-13 Prostaglandin analogs ZA767416B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64527675A 1975-12-29 1975-12-29

Publications (1)

Publication Number Publication Date
ZA767416B true ZA767416B (en) 1977-11-30

Family

ID=24588384

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA767416A ZA767416B (en) 1975-12-29 1976-12-13 Prostaglandin analogs

Country Status (18)

Country Link
US (4) US4085139A (fr)
JP (1) JPS5283351A (fr)
AU (1) AU502349B2 (fr)
BE (1) BE849963A (fr)
CA (1) CA1077473A (fr)
CH (1) CH629747A5 (fr)
DE (1) DE2658207A1 (fr)
ES (1) ES454181A1 (fr)
FR (1) FR2336924A1 (fr)
GB (2) GB1554041A (fr)
HU (1) HU178365B (fr)
IL (1) IL50997A (fr)
MX (1) MX4940E (fr)
NL (1) NL7614389A (fr)
PL (1) PL116421B1 (fr)
SE (1) SE7614584L (fr)
SU (1) SU731895A3 (fr)
ZA (1) ZA767416B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048058A (en) * 1975-08-13 1977-09-13 Standard Oil Company (Indiana) Methods to be used in reforming processes employing multi-metallic catalysts
US4267315A (en) * 1979-05-01 1981-05-12 The Upjohn Company 2-Decarboxy-2-aminomethyl-11a-methano-TXA2 compounds
US4292445A (en) * 1980-04-28 1981-09-29 The Upjohn Company Amide and sulfonamide derivatives of 2-decarboxy-2-aminomethyl-PG-type compounds
CA1241324A (fr) 1984-03-08 1988-08-30 Paul A. Aristoff Derives d'interphenylene carbacycline
US5270049A (en) * 1990-11-09 1993-12-14 Allergan, Inc. 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
HU223068B1 (hu) * 1995-12-20 2004-03-01 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás PGE1 prosztanoid előállítására
WO2010102078A1 (fr) 2009-03-04 2010-09-10 Allergan, Inc. Solution ophtalmique améliorée à base de bimatoprost
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2011008756A1 (fr) 2009-07-13 2011-01-20 Irix Pharmaceuticals Synthèse de prostanoïdes
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
HUP1000284A3 (en) * 2010-06-01 2012-08-28 Avidin Kft Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation
WO2015048736A1 (fr) 2013-09-30 2015-04-02 Irix Pharmaceuticals, Inc. Nouvelles voies de synthèse pour des prostaglandines et des intermédiaires de prostaglandine par métathèse
CN104860860B (zh) * 2015-04-29 2017-09-19 东北制药集团股份有限公司 一种卡前列酯的纯化制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166971A (en) * 1932-09-14 1939-07-25 Ig Farbenindustrie Ag Production of amines
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3647804A (en) * 1970-02-27 1972-03-07 Upjohn Co Cycloalkanecarboxamides
US3852296A (en) * 1971-07-16 1974-12-03 Richardson Merrell Spa Mannich bases of cyclopentanones and cyclopent-2-enones and process of preparing the same
US3987087A (en) * 1971-07-29 1976-10-19 The Upjohn Company Phenyl-substituted prostaglandin-f type analogs
US3954741A (en) * 1972-06-07 1976-05-04 Pfizer Inc. N-substituted prostaglandin carboxamides
US3987085A (en) * 1972-09-15 1976-10-19 The Upjohn Company 8β,11β,12α-PGF2.sub.α compounds

Also Published As

Publication number Publication date
US4073808A (en) 1978-02-14
FR2336924A1 (fr) 1977-07-29
IL50997A (en) 1982-05-31
AU502349B2 (en) 1979-07-19
IL50997A0 (en) 1977-01-31
FR2336924B1 (fr) 1984-08-17
GB1554041A (en) 1979-10-17
SE7614584L (sv) 1977-06-30
PL116421B1 (en) 1981-06-30
BE849963A (fr) 1977-06-29
US4122282A (en) 1978-10-24
US4081478A (en) 1978-03-28
SU731895A3 (ru) 1980-04-30
JPS5283351A (en) 1977-07-12
MX4940E (es) 1983-01-10
JPS5744666B2 (fr) 1982-09-22
US4085139A (en) 1978-04-18
NL7614389A (nl) 1977-07-01
GB1554042A (en) 1979-10-17
ES454181A1 (es) 1977-12-16
HU178365B (en) 1982-04-28
AU2039676A (en) 1978-06-15
CH629747A5 (de) 1982-05-14
DE2658207A1 (de) 1977-07-07
CA1077473A (fr) 1980-05-13

Similar Documents

Publication Publication Date Title
ZA767465B (en) Prostaglandin analogs
IL51189A0 (en) Prostaglandin analogs
ZA77157B (en) Prostaglandin analogs
AU1106976A (en) Prostaglandin analogues
ZA783065B (en) Prostaglandin analogs
ZA763765B (en) 13-cis-pg analogs
ZA774419B (en) Prostaglandin analogs
AU502427B2 (en) Prostaglandin analogs
ZA765652B (en) New prostaglandin salt
GB1554025A (en) Prostaglandin lactones
GB1540483A (en) Prostaglandin containing compositions
ZA761306B (en) Pge-type prostaglandin compositions
IL50997A0 (en) Prostaglandin analogs compositions and process
ZA767541B (en) Prostaglandin analogs
ZA767540B (en) Prostaglandin analogs
ZA772255B (en) Prostaglandin analogs
ZA76512B (en) Prostaglandin analogs
IL52099A0 (en) Prostaglandin analogs
PH16143A (en) Aromatic prostaglandin analogues
ZA781608B (en) Prostaglandin analogs
ZA77160B (en) Prostaglandin analogs
GR58537B (en) Prostaglandin analogues
AU1125476A (en) Analogs of prostanoic acids
ZA7692B (en) Prostaglandin analogs
ZA77158B (en) Prostaglandin analogs